NULISA™- Based Proteomics Services
NULISA™- Based Proteomics Services
NULISA™- Based Proteomics Services
Altheome is proud to be the UK’s first and only Certified Service Provider (CSP) of NULISA™
At Altheome, we are proud to offer cutting-edge biomarker quantification services powered by the NULISA™ proteomics platform. NULISA™ – a next-generation immunoassay technology – combines the precision of immunoassays with the sensitivity and scalability of molecular detection, unlocking deep insights even from scarce or low-abundance samples.
Shape the future of proteomics. Partner with us to leverage the power of NULISA™.
Let's explore a partnership
Let's explore a partnership
Altheome is proud to be the UK’s first and only Certified Service Provider (CSP) of NULISA™
At Altheome, we are proud to offer cutting-edge biomarker quantification services powered by the NULISA™ proteomics platform. NULISA™ – a next-generation immunoassay technology – combines the precision of immunoassays with the sensitivity and scalability of molecular detection, unlocking deep insights even from scarce or low-abundance samples.
Shape the future of proteomics. Partner with us to leverage the power of NULISA™.
Our offerings at Altheome
Depending on your project needs – from focused biomarker quantification to broad profiling – we provide:
Custom single-plex assays: Tailored to your target(s) of interest, ideal for lowabundance proteins, therapeutic monitoring, or bespoke biomarkers.
High-plex multiplex panels: Leveraging NULISA™’s multiplexing capabilities, we can run panels profiling tens to hundreds of proteins simultaneously — suitable for biomarker discovery, translational research, or immunoprofiling.
Flexible readout options: Choose between qPCR-based single-plex readouts or NGSbased multiplex readouts depending on throughput, depth, and study design.
Rigorous quality control and data handling: Our lab infrastructure ensures sample integrity and data reliability, with workflows designed for robustness, reproducibility, and confidentiality.
Our offerings at Altheome
Depending on your project needs – from focused biomarker quantification to broad profiling – we provide:
Custom single-plex assays: Tailored to your target(s) of interest, ideal for lowabundance proteins, therapeutic monitoring, or bespoke biomarkers.
High-plex multiplex panels: Leveraging NULISA™’s multiplexing capabilities, we can run panels profiling tens to hundreds of proteins simultaneously — suitable for biomarker discovery, translational research, or immunoprofiling.
Flexible readout options: Choose between qPCR-based single-plex readouts or NGSbased multiplex readouts depending on throughput, depth, and study design.
Rigorous quality control and data handling: Our lab infrastructure ensures sample integrity and data reliability, with workflows designed for robustness, reproducibility, and confidentiality.
Our offerings at Altheome
Depending on your project needs – from focused biomarker quantification to broad profiling – we provide:
Custom single-plex assays: Tailored to your target(s) of interest, ideal for lowabundance proteins, therapeutic monitoring, or bespoke biomarkers.
High-plex multiplex panels: Leveraging NULISA™’s multiplexing capabilities, we can run panels profiling tens to hundreds of proteins simultaneously — suitable for biomarker discovery, translational research, or immunoprofiling.
Flexible readout options: Choose between qPCR-based single-plex readouts or NGSbased multiplex readouts depending on throughput, depth, and study design.
Rigorous quality control and data handling: Our lab infrastructure ensures sample integrity and data reliability, with workflows designed for robustness, reproducibility, and confidentiality.
Why NULISA™ Matters
Unmatched sensitivity: NULISA™ leverages a proprietary sequential immunocomplex “capture-and-release” mechanism that suppresses background signal by approximately 10,000-fold – enabling detection down to attomolar concentrations (low to sub-fg/mL range).
High dynamic range & multiplexing: Whether you need to measure a single protein or hundreds at once, NULISA™ delivers. The platform supports single-plex assays with qPCR, as well as high-plex multiplexing via next-generation sequencing (NGS).
Minimal sample input: The platform excels when sample volume is limited – e.g. smallvolume plasma, CSF, or other biofluids – making it ideal for precious clinical or preclinical samples
Fully automated, scalable workflow: Using the ARGO™ HT System, NULISA™ assays can be run with minimal hands-on time (< 30 min), delivering single-plex results in < 8 hours, or multiplex NGS-ready libraries within a day – supporting high-throughput studies and large cohorts.
Why NULISA™ Matters
Unmatched sensitivity: NULISA™ leverages a proprietary sequential immunocomplex “capture-and-release” mechanism that suppresses background signal by approximately 10,000-fold – enabling detection down to attomolar concentrations (low to sub-fg/mL range).
High dynamic range & multiplexing: Whether you need to measure a single protein or hundreds at once, NULISA™ delivers. The platform supports single-plex assays with qPCR, as well as high-plex multiplexing via next-generation sequencing (NGS).
Minimal sample input: The platform excels when sample volume is limited – e.g. smallvolume plasma, CSF, or other biofluids – making it ideal for precious clinical or preclinical samples
Fully automated, scalable workflow: Using the ARGO™ HT System, NULISA™ assays can be run with minimal hands-on time (< 30 min), delivering single-plex results in < 8 hours, or multiplex NGS-ready libraries within a day – supporting high-throughput studies and large cohorts.
Why NULISA™ Matters
Unmatched sensitivity: NULISA™ leverages a proprietary sequential immunocomplex “capture-and-release” mechanism that suppresses background signal by approximately 10,000-fold – enabling detection down to attomolar concentrations (low to sub-fg/mL range).
High dynamic range & multiplexing: Whether you need to measure a single protein or hundreds at once, NULISA™ delivers. The platform supports single-plex assays with qPCR, as well as high-plex multiplexing via next-generation sequencing (NGS).
Minimal sample input: The platform excels when sample volume is limited – e.g. smallvolume plasma, CSF, or other biofluids – making it ideal for precious clinical or preclinical samples
Fully automated, scalable workflow: Using the ARGO™ HT System, NULISA™ assays can be run with minimal hands-on time (< 30 min), delivering single-plex results in < 8 hours, or multiplex NGS-ready libraries within a day – supporting high-throughput studies and large cohorts.
Biomarker discovery and validation in research or preclinical settings, especially where protein targets are extremely low abundance.
Biomarker discovery and validation in research or preclinical settings, especially where protein targets are extremely low abundance.
Biomarker discovery and validation in research or preclinical settings, especially where protein targets are extremely low abundance.
Translational neuroscience, immunology, inflammation, rare disease, or any therapeutic area where sensitivity and multiplexing matter.
Translational neuroscience, immunology, inflammation, rare disease, or any therapeutic area where sensitivity and multiplexing matter.
Translational neuroscience, immunology, inflammation, rare disease, or any therapeutic area where sensitivity and multiplexing matter.
Studies with limited sample volume – e.g. CSF, plasma, or other precious biofluids.
Studies with limited sample volume – e.g. CSF, plasma, or other precious biofluids.
Studies with limited sample volume – e.g. CSF, plasma, or other precious biofluids.
Projects requiring high throughput with minimal manual labour and consistent, reproducible data across large sample sets
Projects requiring high throughput with minimal manual labour and consistent, reproducible data across large sample sets
Projects requiring high throughput with minimal manual labour and consistent, reproducible data across large sample sets
Who Should Use NULISA™ Services
NULISA™ is ideally suited for:
Who Should Use NULISA™ Services
NULISA™ is ideally suited for:
Who Should Use NULISA™ Services
NULISA™ is ideally suited for:
Let's discuss it
Let's discuss it
© 2025 Altheome Limited. All Rights Reserved. | Privacy Notice | Cookie Notice
© 2025 Altheome Limited. All Rights Reserved.